Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
In the latest session, BridgeBio Oncology Therapeutics Inc (NASDAQ: BBOT) closed at $12.1 up 4.36% from its previous closing price of $11.59. In other words, the price has increased by $4.36 from its previous closing price. On the day, 1.05 million shares were traded. BBOT stock price reached its highest trading level at $13.98 during the session, while it also had its lowest trading level at $10.7248.
Ratios:
For a deeper understanding of BridgeBio Oncology Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 13.33 and its Current Ratio is at 13.33. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In the most recent recommendation for this company, Morgan Stanley on December 05, 2025, initiated with a Overweight rating and assigned the stock a target price of $20.
On September 17, 2025, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $25.
On September 15, 2025, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $27.H.C. Wainwright initiated its Buy rating on September 15, 2025, with a $27 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BBOT now has a Market Capitalization of 967463232 and an Enterprise Value of 502065184.
Stock Price History:
The Beta on a monthly basis for BBOT is 0.12, which has changed by 0.103809476 over the last 52 weeks, in comparison to a change of 0.19182634 over the same period for the S&P500. Over the past 52 weeks, BBOT has reached a high of $14.87, while it has fallen to a 52-week low of $8.50. The 50-Day Moving Average of the stock is -1.41%, while the 200-Day Moving Average is calculated to be 8.76%.
Shares Statistics:
For the past three months, BBOT has traded an average of 180.10K shares per day and 189280 over the past ten days. A total of 79.20M shares are outstanding, with a floating share count of 43.55M. Insiders hold about 45.56% of the company’s shares, while institutions hold 51.54% stake in the company. Shares short for BBOT as of 1765756800 were 1129317 with a Short Ratio of 8.33, compared to 1763078400 on 976866.
